Cancanelli L - Search Results

1

Radiofrequency Ablation, Cryotherapy Ablation, or Pulsed-Field Ablation to Treat Paroxysmal Atrial Fibrillation Unresponsive to Pharmacological Treatments: Interpreting Efficacy Through Reconstruction of Individual Patient Data From Randomized Trials.

Rivano M, Cancanelli L, Brunoro R, Fasano Celentano CN, Di Spazio L, Mengato D, Messori A. Rivano M, et al. Among authors: cancanelli l. Cureus. 2024 Jul 22;16(7):e65113. doi: 10.7759/cureus.65113. eCollection 2024 Jul. Cureus. 2024. PMID: 39040611 Free PMC article. Review.

2

Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses.

Messori A, Damuzzo V, Rivano M, Cancanelli L, Di Spazio L, Ossato A, Chiumente M, Mengato D. Messori A, et al. Among authors: cancanelli l. Cancers (Basel). 2023 Mar 7;15(6):1633. doi: 10.3390/cancers15061633. Cancers (Basel). 2023. PMID: 36980518 Free PMC article. Review.

3

Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments.

Cancanelli L, Rivano M, Di Spazio L, Chiumente M, Mengato D, Messori A. Cancanelli L, et al. Hematol Rep. 2023 Jan 13;15(1):57-65. doi: 10.3390/hematolrep15010006. Hematol Rep. 2023. PMID: 36648884 Free PMC article. Review.

4

[Application of artificial intelligence for an early comparison of efficacy between new cancer drugs.].

Damuzzo V, Rivano M, Baldo P, Cancanelli L, Di Spazio L, Ossato A, Chiumente M, Messori A, Mengato D. Damuzzo V, et al. Among authors: cancanelli l. Recenti Prog Med. 2022 Nov;113(11):680-687. doi: 10.1701/3907.38896. Recenti Prog Med. 2022. PMID: 36318172 Italian.

5

The "One-to-Many" Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma.

Messori A, Rivano M, Cancanelli L, Damuzzo V, Ossato A, Chiumente M, Mengato D. Messori A, et al. Among authors: cancanelli l. Cureus. 2022 Aug 25;14(8):e28369. doi: 10.7759/cureus.28369. eCollection 2022 Aug. Cureus. 2022. PMID: 36171827 Free PMC article.

6

Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials.

Rivano M, Cancanelli L, Di Spazio L, Mengato D, Chiumente M, Messori A. Rivano M, et al. Among authors: cancanelli l. World J Urol. 2022 Nov;40(11):2609-2615. doi: 10.1007/s00345-022-04143-8. Epub 2022 Sep 9. World J Urol. 2022. PMID: 36083316 Clinical Trial.

7

First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer.

Mengato D, Cancanelli L, Rivano M, Chiumente M, Spazio LD, Messori A. Mengato D, et al. Among authors: cancanelli l. Immunotherapy. 2022 Aug;14(11):871-877. doi: 10.2217/imt-2021-0208. Epub 2022 Jun 13. Immunotherapy. 2022. PMID: 35695029

8

Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy.

Mengato D, Cancanelli L, Di Spazio L, Rivano M, Chiumente M, Messori A. Mengato D, et al. Among authors: cancanelli l. Int J Clin Pharmacol Ther. 2022 Aug;60(8):370-372. doi: 10.5414/CP204243. Int J Clin Pharmacol Ther. 2022. PMID: 35652551 No abstract available.

9

The Degree of Programmed Death-Ligand 1 (PD-L1) Positivity as a Determinant of Outcomes in Metastatic Triple-Negative Breast Cancer Treated With First-Line Immune Checkpoint Inhibitors.

Di Spazio L, Rivano M, Cancanelli L, Chiumente M, Mengato D, Messori A. Di Spazio L, et al. Among authors: cancanelli l. Cureus. 2022 Jan 9;14(1):e21065. doi: 10.7759/cureus.21065. eCollection 2022 Jan. Cureus. 2022. PMID: 35028245 Free PMC article. Review.

10

A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia.

Messori A, Rivano M, Mengato D, Cancanelli L, Di Spazio L, Chiumente M. Messori A, et al. Among authors: cancanelli l. Leuk Lymphoma. 2022 May;63(5):1261-1264. doi: 10.1080/10428194.2021.2022141. Epub 2021 Dec 31. Leuk Lymphoma. 2022. PMID: 34969325 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters